Price Alert

Bright Minds Biosciences ... (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

41.80

-0.74 (-1.74%)

At close: Aug 15, 2025, 3:59 PM

42.13

0.78%

After-hours: Aug 15, 2025, 07:25 PM EDT

Bright Minds Biosciences Balance Sheet Statement

Financials in CAD. Fiscal year is October - September.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	55.68M	57.9M	5.72M	6.19M	5.85M	6.76M	6.75M	8.13M	9.67M	11.21M	11.63M	8.64M	11.47M	15.12M	19.76M	22.01M	25.45M	2.06M
Short-Term Investments	n/a	n/a	n/a	n/a	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	33.68K	33.68K	33.68K	33.68K	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	-0.00	0.00	-0.00	0.00	0.00	-0.00	n/a	n/a	-33.68K	-33.68K	-33.68K	-33.68K	n/a
Receivables	233.57K	67.02K	50.22K	n/a	553.25K	45.04K	36.98K	103.68K	33.36K	59.27K	155.78K	96.44K	208.4K	149.69K	110.15K	77.98K	36.75K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	56.31M	58.22M	5.99M	6.27M	6.5M	6.84M	6.81M	8.38M	9.88M	11.43M	11.95M	8.82M	11.76M	15.41M	20.04M	22.21M	25.74M	2.18M
Property-Plant & Equipment	154.51K	176.99K	117.66K	12.07K	30.19K	48.3K	66.41K	84.53K	102.64K	120.75K	138.86K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2K	2K	2K	2K	2K	2K	2K
Total Long-Term Assets	154.51K	176.99K	117.66K	12.07K	30.19K	48.3K	66.41K	84.53K	102.64K	120.75K	138.86K	2K	2K	2K	2K	2K	2K	2K
Total Assets	56.47M	58.4M	6.1M	6.28M	6.53M	6.89M	6.88M	8.46M	9.99M	11.55M	12.09M	8.82M	11.76M	15.41M	20.04M	22.22M	25.74M	2.18M
Account Payables	551.22K	373.63K	407.55K	149.61K	801.05K	799.6K	182.31K	643.4K	247.95K	322.17K	1.25M	385.32K	994.82K	482.6K	596.57K	322.86K	409.24K	95.39K
Deferred Revenue	n/a	n/a	n/a	n/a	-801.05K	-799.6K	n/a	-643.4K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	637.97K	461.52K	528.68K	178.63K	845.79K	854.16K	280.86K	720.8K	1.01M	528.1K	1.47M	385.32K	1M	489.6K	638.57K	322.86K	409.24K	95.39K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	88.85K	110.07K	39.58K	n/a	n/a	n/a	n/a	14.02K	34.73K	54.56K	71.98K	385.32K	994.82K	482.6K	n/a	n/a	n/a	n/a
Total Liabilities	726.81K	571.59K	568.26K	178.63K	845.79K	854.16K	280.86K	734.81K	1.04M	582.66K	1.54M	385.32K	1M	489.6K	638.57K	322.86K	409.24K	95.39K
Total Debt	166.6K	182.73K	118.96K	14.02K	34.73K	54.56K	73.55K	91.41K	108.32K	124.48K	139.91K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	89.89M	89.02M	35.42M	35.05M	35.05M	35.05M	33.91M	33.91M	33.91M	33.68M	32.24M	27.19M	27.17M	27.18M	27.08M	27.05M	27.24M	3M
Retained Earnings	-37.25M	-34.3M	-34.35M	-33.58M	-33.81M	-33.23M	-31.55M	-30.02M	-28.56M	-26.51M	-24.17M	-21.21M	-18.56M	-14.07M	-9.21M	-6.34M	-2.81M	-1.31M
Comprehensive Income	3.1M	3.11M	4.01M	3.8M	4.44M	3.39M	3.4M	3M	2.76M	2.96M	2.48M	2.45M	2.15M	1.85M	1.57M	1.22M	925.55K	397.71K
Shareholders Equity	55.74M	57.83M	5.54M	6.1M	5.69M	6.03M	6.6M	7.73M	8.95M	10.97M	10.54M	8.43M	10.76M	14.92M	19.4M	21.89M	25.33M	2.09M
Total Investments	n/a	n/a	n/a	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	86.25K	119.93K	119.93K	119.93K	33.68K	n/a